Changming Qin

Changming Qin is a Senior Manager at Ipsen, where they lead technical and manufacturing activities of drug substances to support pre-clinical and clinical programs. With a background as a Process Scientist at Vertex Pharmaceuticals and a Manager at Albireo Pharma, they have extensive experience in drug substance development and regulatory filings. Previously, Changming worked as a Postdoctoral Researcher at Boston College, focusing on the selective allylation of fluorinated ketones, and as a Research Assistant at The University of Hong Kong, where they developed gold-catalyzed isomerization reactions. Changming is currently pursuing a Master of Science and a Doctor of Philosophy in Organic Chemistry, alongside a Bachelor of Science in Chemistry from Wenzhou University, Emory University, and Ludong University, respectively.